Difficulty: Medium
Average Score: 92%
Practice
Extrapyramidal reactions can be treated by:
Correct answer
B
Rationale
In the treatment of extrapyramidal reactions, such as those caused by antipsychotic medications, the correct option is B) Benztropine mesylate. Benztropine mesylate is an anticholinergic medication that helps to reduce the symptoms of extrapyramidal reactions by blocking the action of acetylcholine in the brain, thereby restoring the balance of neurotransmitters.
Levodopa (option A) is primarily used in the treatment of Parkinson's disease and would not be effective in treating extrapyramidal reactions. Bromocriptine (option C) is a dopamine agonist commonly used to treat Parkinson's disease and hyperprolactinemia, but it is not the first-line treatment for extrapyramidal reactions. Option D, Dopamine, is not a medication but rather a neurotransmitter involved in the pathophysiology of extrapyramidal reactions.
In an educational context, it is crucial for healthcare professionals, particularly those in pharmacology and psychiatry, to understand the appropriate pharmacological treatments for extrapyramidal reactions. By selecting the correct medication, Benztropine mesylate, healthcare providers can effectively manage and alleviate these adverse side effects, ensuring the well-being and safety of their patients.
Levodopa (option A) is primarily used in the treatment of Parkinson's disease and would not be effective in treating extrapyramidal reactions. Bromocriptine (option C) is a dopamine agonist commonly used to treat Parkinson's disease and hyperprolactinemia, but it is not the first-line treatment for extrapyramidal reactions. Option D, Dopamine, is not a medication but rather a neurotransmitter involved in the pathophysiology of extrapyramidal reactions.
In an educational context, it is crucial for healthcare professionals, particularly those in pharmacology and psychiatry, to understand the appropriate pharmacological treatments for extrapyramidal reactions. By selecting the correct medication, Benztropine mesylate, healthcare providers can effectively manage and alleviate these adverse side effects, ensuring the well-being and safety of their patients.